Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIMARAN: CHF 5993 vs CHF 1535 in Uncontrolled Asthma
NCT02676076Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Feb 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glycopyrronium bromide in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Feb 2016; status: completed.
02
Drugs
glycopyrronium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02676076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02676076.